Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Phase 1 Study of GS101 Injection [Phase 1]
A Phase 1 clinical trial update for GS101 Injection investigating safety and tolerability in Atopic Dermatitis, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to Interleukin-4 Receptor Alpha(IL-4Rα) Inhibitors: A Prospective, Multicenter, Real-World Study [NA]
A prospective, multicenter real-world study assessing the efficacy and safety of switching to Ivarmacitinib in adults with moderate-to-sever…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis
A University of Pennsylvania-sponsored study is investigating filaggrin gene mutations in Latinx patients with atopic dermatitis, and the tr…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants [Phase 1]
A dose-escalation Phase 1 trial of HXN5003 in healthy participants is not yet recruiting, sponsored by Helixon Biotechnology (Suzhou) Co., L…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis [Phase 1]
Phase 1 clinical trial evaluating IBI3033 for moderate-to-severe atopic dermatitis; recruitment has not yet begun.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis [Phase 1]
This clinical trial update reports on evaluating the safety and tolerability of baricitinib in patients with Hyper-IgE syndrome due to STAT3…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Sebum Metabolomics and Lipidomics for Clinical Applications [NA]
Clinical trial registry entry for a study on sebum metabolomics and lipidomics for clinical applications, sponsored by National Taiwan Unive…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis [Phase 2]
This clinical trial entry describes a Phase 2 dose-ranging study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 study evaluating orally administered KT-621 for moderate to severe atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update showing ENV-294 is being studied in adults with moderate-to-severe atopic dermatitis and is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases [Phase 1]
BeiGene is conducting a Phase 1 trial to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-asc…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating BFB759 in adults with moderate to severe atopic dermatitis is currently recruiting. The sponsor is Bluef…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
A clinical trial is evaluating Stapokibart Injection for Atopic Dermatitis and is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
A clinical trial update describing real-world effectiveness of abrocitinib in adults with moderate-to-severe atopic dermatitis who had inade…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Nigella Sativa Oil for Eczematous Otitis Externa [NA]
A clinical trial is recruiting to evaluate Nigella Sativa Oil for eczematous otitis externa.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study Evaluating APG777 in Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update for APG777 in atopic dermatitis, with the study currently active and not recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase III clinical trial evaluating TQH2722 Injection for moderate-to-severe atopic dermatitis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis [Phase 2]
Phase 2 study evaluating whether food-specific and component IgE thresholds can predict milk allergy or peanut allergy in people with elevat…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis [Phase 3]
A Phase III study evaluating MG-K10 for adolescents with moderate-to-severe atopic dermatitis; the trial is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis [Phase 3]
This document reports a Phase 3 clinical trial evaluating two subcutaneous doses of amlitelimab versus treatment withdrawal in participants …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Dupilumab De-escalation in Pediatric Atopic Dermatitis [Phase 4]
Phase 4 clinical trial evaluating de-escalation strategies for dupilumab in pediatric atopic dermatitis is currently recruiting. The study i…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of Tapinarof Cream 1% in infants and toddlers (ages 3 months to <24 months) with…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis [Phase 3]
Phase 3 clinical trial update evaluating Lebrikizumab for moderate-to-severe atopic hand and foot dermatitis. The study is currently active …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden [Phase 4]
Phase 4 study to evaluate Lebrikizumab in adults and adolescents with moderate atopic dermatitis and high itch burden; recruitment is ongoin…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab [Phase 3]
This clinical trial update reports ongoing recruitment for a Phase 3 study evaluating Upadacitinib in adults with moderate-to-severe Atopic …